These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24552136)
1. Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013. Kamikawa Y; Mori Y; Nagayama T; Fujisaki J; Hirabayashi D; Sakamoto R; Hamada T; Sugihara K BMC Oral Health; 2014 Feb; 14():14. PubMed ID: 24552136 [TBL] [Abstract][Full Text] [Related]
2. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443 [TBL] [Abstract][Full Text] [Related]
3. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Lindberg E; Hammarström H; Ataollahy N; Kondori N Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717 [TBL] [Abstract][Full Text] [Related]
4. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058 [TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibility of Candida isolates at one institution. Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093 [TBL] [Abstract][Full Text] [Related]
6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
7. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Danby CS; Boikov D; Rautemaa-Richardson R; Sobel JD Antimicrob Agents Chemother; 2012 Mar; 56(3):1403-6. PubMed ID: 22232293 [TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Wang H; Xu YC; Hsueh PR Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis. Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698 [TBL] [Abstract][Full Text] [Related]
11. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. González GM; Elizondo M; Ayala J J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104 [TBL] [Abstract][Full Text] [Related]
15. [Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool]. Tashiro M; Murakami H; Yoshizawa S; Tateda K; Yamaguchi K Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):15-20. PubMed ID: 23115940 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738 [TBL] [Abstract][Full Text] [Related]
17. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Sojakova M; Liptajova D; Borovsky M; Subik J Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile. Silva V; Alvarado D; Diaz MC Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]